Joon Lee
Stock Analyst at Truist Securities
(4.74)
# 112
Out of 4,754 analysts
114
Total ratings
59.8%
Success rate
40.99%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Joon Lee
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AXSM Axsome Therapeutics | Maintains: Buy | $190 → $200 | $126.84 | +57.68% | 5 | Feb 19, 2025 | |
| CRSP CRISPR Therapeutics AG | Maintains: Buy | $100 → $120 | $43.79 | +174.07% | 5 | Feb 12, 2025 | |
| VRTX Vertex Pharmaceuticals | Maintains: Buy | $460 → $520 | $483.33 | +7.59% | 3 | Feb 11, 2025 | |
| LRMR Larimar Therapeutics | Initiates: Buy | $18 | $2.86 | +529.37% | 1 | Jan 29, 2025 | |
| PRAX Praxis Precision Medicines | Maintains: Buy | $150 → $175 | $38.53 | +354.19% | 4 | Jan 21, 2025 | |
| ARGX argenx SE | Reiterates: Buy | $660 → $700 | $629.93 | +11.12% | 12 | Jan 14, 2025 | |
| VRNA Verona Pharma | Reiterates: Buy | $44 → $57 | $68.19 | -16.41% | 6 | Jan 8, 2025 | |
| SLDB Solid Biosciences | Initiates: Buy | $16 | $5.33 | +200.47% | 1 | Jan 8, 2025 | |
| WVE Wave Life Sciences | Maintains: Buy | $17 → $36 | $10.46 | +244.33% | 3 | Nov 12, 2024 | |
| CPRX Catalyst Pharmaceuticals | Maintains: Buy | $30 → $36 | $23.06 | +56.11% | 7 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $8 | $1.81 | +341.99% | 7 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $13 → $8 | $7.24 | +10.57% | 11 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $17 | $10.14 | +67.74% | 7 | Oct 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $65 → $76 | $60.65 | +25.31% | 7 | Sep 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $118 → $90 | $70.65 | +27.40% | 2 | Sep 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $40 | $4.75 | +742.11% | 6 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $120 | $9.96 | +1,105.42% | 3 | Jun 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $120 | $26.78 | +348.10% | 7 | Jun 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $65 | $17.02 | +281.90% | 5 | Mar 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $200 | $142.73 | +40.12% | 2 | Mar 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 → $5 | $1.62 | +209.60% | 7 | Sep 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $18 | $3.96 | +355.12% | 1 | May 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $280 | $2.58 | +10,741.79% | 1 | Oct 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $27 → $34 | $15.85 | +114.51% | 1 | Mar 16, 2021 |
Axsome Therapeutics
Feb 19, 2025
Maintains: Buy
Price Target: $190 → $200
Current: $126.84
Upside: +57.68%
CRISPR Therapeutics AG
Feb 12, 2025
Maintains: Buy
Price Target: $100 → $120
Current: $43.79
Upside: +174.07%
Vertex Pharmaceuticals
Feb 11, 2025
Maintains: Buy
Price Target: $460 → $520
Current: $483.33
Upside: +7.59%
Larimar Therapeutics
Jan 29, 2025
Initiates: Buy
Price Target: $18
Current: $2.86
Upside: +529.37%
Praxis Precision Medicines
Jan 21, 2025
Maintains: Buy
Price Target: $150 → $175
Current: $38.53
Upside: +354.19%
argenx SE
Jan 14, 2025
Reiterates: Buy
Price Target: $660 → $700
Current: $629.93
Upside: +11.12%
Verona Pharma
Jan 8, 2025
Reiterates: Buy
Price Target: $44 → $57
Current: $68.19
Upside: -16.41%
Solid Biosciences
Jan 8, 2025
Initiates: Buy
Price Target: $16
Current: $5.33
Upside: +200.47%
Wave Life Sciences
Nov 12, 2024
Maintains: Buy
Price Target: $17 → $36
Current: $10.46
Upside: +244.33%
Catalyst Pharmaceuticals
Nov 11, 2024
Maintains: Buy
Price Target: $30 → $36
Current: $23.06
Upside: +56.11%
Nov 5, 2024
Maintains: Buy
Price Target: $12 → $8
Current: $1.81
Upside: +341.99%
Oct 30, 2024
Maintains: Hold
Price Target: $13 → $8
Current: $7.24
Upside: +10.57%
Oct 22, 2024
Maintains: Buy
Price Target: $12 → $17
Current: $10.14
Upside: +67.74%
Sep 30, 2024
Maintains: Buy
Price Target: $65 → $76
Current: $60.65
Upside: +25.31%
Sep 17, 2024
Maintains: Buy
Price Target: $118 → $90
Current: $70.65
Upside: +27.40%
Aug 14, 2024
Maintains: Buy
Price Target: $60 → $40
Current: $4.75
Upside: +742.11%
Jun 24, 2024
Maintains: Buy
Price Target: $120
Current: $9.96
Upside: +1,105.42%
Jun 17, 2024
Maintains: Buy
Price Target: $120
Current: $26.78
Upside: +348.10%
Mar 25, 2024
Reiterates: Buy
Price Target: $65
Current: $17.02
Upside: +281.90%
Mar 20, 2024
Reiterates: Buy
Price Target: $200
Current: $142.73
Upside: +40.12%
Sep 20, 2023
Maintains: Buy
Price Target: $6 → $5
Current: $1.62
Upside: +209.60%
May 10, 2023
Initiates: Buy
Price Target: $18
Current: $3.96
Upside: +355.12%
Oct 20, 2021
Initiates: Buy
Price Target: $280
Current: $2.58
Upside: +10,741.79%
Mar 16, 2021
Upgrades: Buy
Price Target: $27 → $34
Current: $15.85
Upside: +114.51%